Robert & Gloriacancro is categorized under Physical Medicine, Physician/Surgeon in Mount Kisco, NY and active since 2010.
Robert & Gloriacancro was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Robert Cancro at the company’s single location by writing to 118 Mclain St, Mount Kisco, New York NY 10549 or by phoning (914) 241-1131. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Robert & Gloriacancro |
| Contact Person: | Robert Cancro |
| Address: | 118 Mclain St, Mount Kisco, New York 10549 |
| Phone Number: | (914) 241-1131 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Robert & Gloriacancro was started in 2010 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Cancro for inquiries that concern Robert & Gloriacancro by calling the company number (914) 241-1131, as your correspondence is most welcome. Additionally, the physical location of the single location of Robert & Gloriacancro can be found at the coordinates 41.208264,-73.716723 as well as the street address 118 Mclain St in Mount Kisco, New York 10549.
For its online presence, you may visit Robert & Gloriacancro’s website at and engage with its social media outlets through on Twitter and on Facebook.